RENB

RENB

USD

Renovaro Inc. Common Stock

$1.420+0.230 (19.328%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.190

Máximo

$1.420

Mínimo

$1.420

Volumen

0.12M

Fundamentos de la Empresa

Capitalización de Mercado

33.8M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.22M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.11Actual $1.420Máximo $21

Noticias Relacionadas

AccessWire

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Measure taken to Comply with Nasdaq Rule 5550 Regarding Minimum Bid Price LOS ANGELES, CA / ACCESS Newswire / September 24, 2025 / Lunai Bioworks, Inc. ("Lunai Bioworks" or the

Ver más
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split
AccessWire

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

BETHESDA, MD / ACCESS Newswire / September 11, 2025 / Lunai Bioworks Inc.'s wholly-owned subsidiary BioSymetrics Inc. today announced the award of a prestigious Small Business Technology Transfer

Ver más
Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics
AccessWire

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 9, 2025 / Lunai Bioworks Inc. , an AI-powered drug

Ver más
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery
AccessWire

Lunai Bioworks Strengthens European Strategy Through Restructuring

Company remains committed to Europe with a streamlined, growth-focused approach. LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 8, 2025 / Lunai Bioworks Inc. , an AI-powered drug discovery and

Ver más
Lunai Bioworks Strengthens European Strategy Through Restructuring

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.